GMCH (Government Medical College and Hospital) in Nagpur has received ICMR (Indian Council of Medical Research) nod for conducting clinical trials of convalescent plasma therapy to treat critically ill COVID-19 patients. GMCH is among the 21 hospitals in the country to have received the approval.
Out of these 21 hospitals, five are from Maharashtra, four from Gujarat, two from Rajasthan, two from Madhya Pradesh, two from Tamil Nadu, two from Uttar Pradesh and one each from Punjab, Karnataka, Telangana and Haryana. Around 90 hospitals from across the country have also shown interest in conducting such trials and are under consideration.
Plasma therapy involves injecting the COVID-19 patient with the blood plasma of a recovered patient. People who get cured from COVID-19 develop anti-bodies, which drive the virus away. These anti-bodies from cured patient can be used to treat positive patients through convalescent plasma therapy.